KOSDAQ · Healthcare · ₩164B
₩5,740+1.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.8% · as of 26.10.27
Among 15 신약 개발 peers
Quarterly Revenue Growth
“검사 수요는 커졌지만 실제 돈벌이는 더 기다려야 해요.”
In the company's words · 2026 2분기 filing